Niger vs Somalia: Cause of death, by non-communicable diseases, ages 0-4, male
Niger
4.7%
in 2021
Somalia
5.1%
in 2021
Niger rank
181st
Somalia rank
178th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Niger
- Somalia
How they compare
Somalia currently reports 5.1% against 4.7% in Niger, a difference of 0.4%.
That makes Somalia's figure about 1.1 times Niger's.
Across all 6 years both countries report, Somalia has been ahead every year.
Niger ranks 181st and Somalia ranks 178th of 185 countries.
Somalia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 3.2% | 0.9% | Somalia |
| 2010s | 4.1% | 5.1% | 1.0% | Somalia |
| 2020s | 4.7% | 5.0% | 0.3% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Niger or Somalia?
- Somalia, at 5.1% against 4.7% in Niger as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Niger and Somalia?
- 0.4%, with Somalia ahead.
- How many years of comparable data are there for Niger and Somalia?
- 6 years are reported by both, from 2000 to 2021.
- How do Niger and Somalia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Niger ranks 181st and Somalia ranks 178th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.